The Florida Mosquito Zika Transmission Scare Continues

Andrew Black
Published Online: Thursday, Jul 28, 2016
Last week, information was released that the state of Florida was testing their mosquitos for Zika, as a person who hasn’t traveled became infected with the virus. Although the CDC nor Florida health officials have confirmed positive test results for Zika in their mosquitos yet, three more cases of non-travel infections are now under investigation – totaling of 4 cases.
With these new reports surfacing, the potential chance of the Zika virus being transmitted through mosquitos in the U.S. are starting to seem a little more likely, although nothing is confirmed yet. CDC spokesman Tom Skinner said “Evidence is mounting to suggest local transmission via mosquitoes is going on in South Florida."
The four Florida cases under investigation are in Broward or Miami-Dade counties, according to the state health department.
Epidemiologists are surveying households and neighbors within a 150-yard radius around the residence of the person who was diagnosed with the Zika virus which would constitute the flying range of the mosquitoes that carry the virus.
Florida public health staff will collect urine samples from residents to test for the virus. These results will help the department determine the number of people affected. Health officials also are giving out Zika prevention kits and mosquito repellent.
We will wait for the update on whether the local Florida transmission is confirmed or not. If confirmed, it will be the first U.S. mosquito transmission to be recorded.
In addition to the possible cases of non-travel related transmission, Florida has a reported 328 travel-related cases of Zika. The state is monitoring 53 pregnant women who had Zika infections.

Zika Update

US States
Locally acquired mosquito-borne cases reported: 0 (Under Investigation)
Travel-associated cases reported: 1,403
Laboratory acquired cases reported:  1
Total: 1,404
Sexually transmitted: 15
Guillain-Barré syndrome: 5

Latest Articles
Positive initial results from a Phase 1A clinical trial evaluating setmelanotide (RM-492) for the treatment of rare genetic disorders of obesity were reported.
He’s a patient, an educator, and an advocate. Huntington's Disease patient and Bellingham researcher Jeff Carroll is a triple threat.
Dr Gavin Rumbaugh, PhD of Scripps Florida Research Institute was awarded an NIMH-funded grant for the therapeutic development of Syngap1.
Cooper sits down with RDR to talk about A4250, why it’s so important to children with PFIC, and just how Albireo prioritizes treatment for rare diseases.
$vacMongoViewPlus$ $vAR$